Global Antacids Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the antacids market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Antacids Market In The Period 2029-2034?

The oxycodone drugs market has demonstrated strong growth over recent years. It is anticipated to expand from $5.62 billion in 2024 to $5.98 billion in 2025, at a compound annual growth rate (CAGR) of 6.4%. This historical growth can be attributed to an aggressive marketing campaign for OxyContin, which was promoted for both chronic non-malignant pain and cancer. The increase in OxyContin prescriptions for non-cancer-related pain subsequently heightened the demand for these drugs. Furthermore, synthetic opiates like oxycodone became more widely available in the market after the Second World War.

The oxycodone drugs market size is anticipated to expand significantly in the coming years, projected to reach $7.66 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth during the forecast period is primarily fueled by the increasing incidence of chronic pain, a rising volume of surgical procedures, continuous advancements in the product pipeline expected to stimulate expansion, improvements in drug delivery systems, and a growing global elderly population experiencing a higher frequency of chronic pain. Key developments in the forecast period encompass an escalating demand for abuse-deterrent formulations (ADFS), the creation of innovative delivery systems, the expanded application of combination therapies, and technological progress in manufacturing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

What Strategic Drivers Are Accelerating The Antacids Market Expansion?

The substantial prevalence of orthopedic conditions is predicted to fuel the expansion of the oxycodone drug market in the future. These disorders encompass various musculoskeletal ailments involving bones, joints, ligaments, tendons, and muscles, resulting in discomfort, reduced movement, and functional restrictions. An increasing occurrence of orthopedic problems stems from factors such as an aging demographic, inactive routines, excess weight, athletic injuries, and workplace risks. Oxycodone medications find application in orthopedic cases to mitigate both acute and persistent pain arising from issues like fractures, joint trauma, or post-operative soreness, offering significant relief through their interaction with pain receptors in the central nervous system. As an illustration, in October 2023, data from the Institute for Health Metrics and Evaluation, a US-based research institution, indicated that the anticipated instances of musculoskeletal disorders (orthopedic disorders) are set to increase by 115% (ranging from 107–124%) between 2020 and 2050, reaching an approximate 1,060 million prevalent cases by 2050. Consequently, the significant burden imposed by orthopedic disorders is propelling the expansion of the oxycodone drug market.

What Is The Detailed Segment Distribution Of The Antacids Market?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

How Are Global Trends Impacting The Development Of The Antacids Market?

Major companies operating in the oxycodone drug market are dedicating their efforts to developing innovative drugs, such as oxycodone immediate-release (IR) tablets, aimed at reducing drug abuse via injection and the intranasal route. Oxycodone immediate-release (IR) tablets are a specific formulation of the opioid analgesic medication oxycodone, designed to provide rapid pain relief. For instance, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, launched RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. RoxyBond has received authorization from the U.S. Food and Drug Administration (FDA) as an opioid agonist for treating severe pain that necessitates an opioid analgesic when other alternatives are insufficient. It is engineered with advanced technology to deter misuse and abuse, making it difficult to tamper with either physically or chemically.

Who Are The Major Stakeholders Operating In The Antacids Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Antacids Market?

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

Browse Through More Reports Similar to the Global Antacids Market 2025, By The Business Research Company

Narcotic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

Antiparasitic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795